Tokyo

London

New York

Register

Sign In

EUR/USD

1.1664

0.0036

0.31%

GBP/USD

1.2995

0.0029

0.23%

USD/JPY

111.13

-0.7425

-0.66%

USD/CHF

0.9459

-0.0056

-0.59%

EUR/GBP

0.8976

0.0008

0.08%

USD/CAD

1.2542

-0.0054

-0.43%

NZD/USD

0.7455

0.0052

0.71%

EUR/JPY

129.61

-0.4680

-0.36%

EUR/CHF

1.1033

-0.0031

-0.28%

AURINIA PHARMS INC

NASDAQ: AUPHHealthcare / Biotechnology / Canada
6.55-0.05-0.76%Vol 1 656 4871Y Perf 116.17%
Jul 21st, 2017 16:00
BID6.52 ASK6.61
Open6.59 Previous Close6.60
Pre-Market6.61 After-Trading6.58
 0.01 0.15%  0.03 0.46%
Target Price
11.00 
Analyst Rating
Strong Buy 1.22
Potencial %
67.94 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)550 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
54.66 
Earnings Date
4th Aug 2017

Today's Price Range

6.496.78

 

52wk Range

1.7410.54

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Strong Sell
Performance
1 Month
-1.93%
3 Months
-5.71%
6 Months
160.87%
1 Year
116.17%
3 Years
62.56%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
AUPH6.55-0.0500-0.76
AAPL150.27-0.0700-0.05
GOOG972.924.77000.49
MSFT73.79-0.4300-0.58
XOM80.12-0.7400-0.92
WFC54.17-0.7100-1.29
JNJ135.31-1.2600-0.92
FB164.43-0.1000-0.06
GE25.91-0.7800-2.92
JPM90.89-0.3100-0.34
...

TickerPriceChg.%52 Week High
CTAS138.439.19139.39
COF87.948.5596.92
ETFC41.635.1341.83
SYF30.874.5438.06
MCO132.574.25133.62
FITB26.182.7128.97
NFLX188.542.69191.50
KMX66.092.6669.11
VRTX163.172.41167.00
AAP105.271.98177.83
CCI99.171.95104.68
DFS62.531.8974.33
AEP69.981.8672.97
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 24.30
Current Ratio 24.60
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin97.30
EBIT Margin-19 763.30
EBITDA Margin-18 773.50
Pre-tax Profit Margin-5 640.90
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.21
PS Ratios 4 341.64
Price to Cash Flow -
Price to Free Cash Flow -28.40
Cash Flow Per Share -0.71
Price to Tangible Book3.37
Book Value per Share2.07
Enterprise Value (in ths.)310 688
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-84.12
ROE last 12 Months -75.63
Return on Assets (5Y Avg) -10.80
ROA last 12 Months -57.77
Return on Capital (5Y Avg) -119.04
ROC last 12 Months -75.32
Return on invested Capital Q -49.87
Return on invested Capital Y-83.42
Assets Turnover0.00
Receivables Turnover1.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)147
Revenue per Share 0.00
Revenue Growth 3 Years -33.92
Revenue Growth 5 Years -52.03
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.11-0.20-81.82
Q04 2016-0.10-0.22-120.00
Q03 2016-0.14-0.19-35.71
Q02 2016-0.15-0.146.67
Q01 2016-0.14-0.137.14
Q04 2015-0.16-0.160.00
Q03 2015-0.23-0.1821.74
Q02 2015-0.24-0.0291.67
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.13-18.18Negative
9/2017 QR-0.13-18.18Negative
12/2017 FY-1.07-98.15Negative
12/2018 FY-0.61-19.61Negative
Next Report Date4th Aug 2017
Estimated EPS Next Report-0.13
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume1 656 487
Shares Outstanding (in ths.)83 270
Trades Count4 191
Dollar Volume10 648 104
Avg. Volume5 379 585
Avg. Weekly Volume3 911 616
Avg. Monthly Volume1 819 794
Avg. Quarterly Volume2 465 225

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%37%

Bearish Bullish

64%36%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.22
Strong Buy
1.22
Strong Buy
1.22

There are no comments yet.

News

Plus500
x